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1. INTRODUCTION 
DIABETIC MELLITUS 
  Diabetic millets1 often referred to simply as diabetes (Ancient Greek: 
diabetes‖ to pass through [urine]‖) is a syndrome of disorder metabolism, usually due 
to a combination of hereditary and environment causes, resulting in abnormally high 
blood sugar level (hyperglycemia).Diabetes is described as starvation in the midst of 
plenty. Because the body will have high amount of glucose level but the cells are 
incapable of consume it because of osmotic difference Insulin is a hormone produced 
in the pancreas, which enable body cells to absorb glucose, to turn into energy. If the 
body cells cannot absorb the glucose, the glucose accumulates in the blood 
(hyperglycemia), leading to acute metabolic complications including keto acidosis 
and in the long term contribute to chronic micro-vascular complications.  
TYPES OF DIABETES MELLITUS
2-4 
The type of diabetes is based on the presumed etiology they are 
 1. Type 1 diabètes or Insulin dependent diabetes mellitus (IDDM) 
 2. Type 2 diabètes or Non Insulin dependent diabetes mellitus (NIDDM) 
 3. Gestational Diabetes (Pregnancy diabetic). 
1. TYPE 1 DIABETES 
  Insulin-dependent (Type I) diabetes mellitus is a chronic disease 
characterized by hyperglycemia, impaired metabolism and storage of important 
nutrients, evidence of autoimmunity, and long-term vascular and neurologic 
complications. 
   Insulin secretary function is limited. Cell membrane binding is not 
primarily involved. The goal of treatment is to relieve symptoms and to achieve blood 
glucose levels as close to normal as possible without severe hypoglycemia. However, 
even with education and self-monitoring of the blood glucose level, attaining 
recommended target values (plasma glucose level less than 8.0 mmol/L before main 
meals for adults) remains difficult. 
.   Therapy with one or two injections per day of mixed short-acting or 
intermediate-acting insulin preparations is a compromise between convenience and 
the potential for achieving target plasma glucose levels. 
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   Intensive insulin therapy with multiple daily injections or continuous 
infusion with an insulin pump improves mean glycated hemoglobin levels; however, 
it increases rates of severe hypoglycemia and has not been shown to decrease the 
incidence of clinically significant renal, retinal or neurologic dysfunction. Future 
prospects include automated techniques of insulin delivery, immunosuppressant to 
preserve endogenous insulin secretion and islet transplantation. 
 Type 1 diabetes (IDDM) is characterized by loss of the insulin producing beta 
cells of the islet of Langerhans in the pancreas leading deficiency. In type 1 diabetes, 
the body does not produce insulin, and daily insulin injections are required. Type 1 
diabetes is usually diagnosed during childhood or early adolescence and it affects 
about 1 in every 600 children. 
It has two forms: 
Immune Mediated Diabetes Mellitus: Results from a cellular mediated autoimmune 
destruction of the beta cells of the pancreas. 
Idiopathic Diabetes Mellitus: Refer to forms of the disease that have unknown 
etiologies. 
The majority of diabetes 1 is of the immune medicated in nature, where beta cells loss 
is a T cell mediated auto immune attack. 
SYMPTOMS OF TYPE 1 DIABETIC 
Type 1 diabetes signs and symptoms can come on quickly and may include: 
 Increased thirst and frequent urination 
 Extreme hunger 
 Weight loss 
 Fatigue 
 Blurred vision 
CAUSES OF TYPE 1 DIABETIC. 
The exact cause of type 1 diabetes is unknown. In most people with type 1 diabetes, 
the body's own immune system which normally fights harmful bacteria and viruses 
mistakenly destroys the insulin-producing (islet) cells in the pancreas. Genetics may 
play a role in this process, and exposure to certain viruses may trigger the disease. 
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1) A family history. Anyone with a parent or sibling with type 1 diabetes has a 
slightly increased risk of developing the condition. 
2) Genetics. The presence of certain genes indicates an increased risk of 
developing type 1 diabetes. In some cases — usually through a clinical trial 
genetic testing can be done to determine if someone who has a family history 
of type 1 diabetes is at increased risk of developing the condition. 
3) Geography. The incidence of type 1 diabetes tends to increase as you travel 
away from the equator. People living in Finland and Sardinia have the highest 
incidence of type 1 diabetes — about two to three times higher than rates in 
the United States and 400 times that of people living in Venezuela 
4) Viral exposure. Exposure to Epstein-Barr virus, coxsackievirus, mumps virus 
or cytomegalovirus may trigger the autoimmune destruction of the islet cells, 
or the virus may directly infect the islet cells. 
5) Early vitamin D. Research suggests that vitamin D may be protective against 
type 1 diabetes. However, early drinking of cow's milk — a common source of 
vitamin D — has been linked to an increased risk of type 1 diabetes. 
6) Other dietary factors. Omega-3 fatty acids may offer some protection against 
type 1 diabetes. Drinking water that contains nitrates may increase the risk. 
Consuming dairy products, particularly cow's milk, may increase infants' risk 
of the disease. Additionally, the timing of the introduction of cereal into a 
baby's diet may affect risk. One clinical trial found that between ages 3 and 7 
months appears to be the optimal time for introducing cereal. 
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              COMPLICATIONS OF TYPE 1 DIABETIC MELLITUS 
Figure 1: complication of diabetic mellitus
5 
 
Type 1 diabetes can affect major organs in your body, including heart,    
blood vessels, nerves, eyes and kidneys. Keeping the blood sugar level close to 
normal most of the time can dramatically reduce the risk of many complications. 
Long-term complications of type 1 diabetes develop gradually, over 
years. The earlier you develop diabetes — and the less controlled your blood 
sugar the higher the risk of complications. Eventually, diabetes complications may 
be disabling or even life-threatening. 
1) Heart and blood vessel disease. Diabetes dramatically increases your risk of 
various cardiovascular problems, including coronary artery disease with chest 
pain (angina), heart attack, stroke, narrowing of the arteries (atherosclerosis) 
and high blood pressure. 
2) Nerve damage (neuropathy). Excess sugar can injure the walls of the tiny 
blood vessels (capillaries) that nourish your nerves, especially in the legs. This 
can cause tingling, numbness, burning or pain that usually begins at the tips of 
the toes or fingers and gradually spreads upward. Poorly controlled blood 
sugar could cause you to eventually lose all sense of feeling in the affected 
limbs. Damage to the nerves that affect the gastrointestinal tract can cause 
problems with nausea, vomiting, diarrhea or constipation. For men, erectile 
dysfunction may be an issue. 
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3) Kidney damage (nephropathy). The kidneys contain millions of tiny blood 
vessel clusters that filter waste from your blood. Diabetes can damage this 
delicate filtering system. Severe damage can lead to kidney failure or 
irreversible end-stage kidney disease, which requires dialysis or a kidney 
transplant. 
4) Eye damage. Diabetes can damage the blood vessels of the retina (diabetic 
retinopathy), potentially leading to blindness. Diabetes also increases the risk 
of other serious vision conditions, such as cataracts and glaucoma. 
5) Foot damage. Nerve damage in the feet or poor blood flow to the feet 
increases the risk of various foot complications. Left untreated, cuts and 
blisters can become serious infections. Severe damage might require toe, foot 
or even leg amputation. 
6) Skin and mouth conditions. Diabetes may leave you more susceptible to skin 
problems, including bacterial and fungal infections. Gum infections also may 
be a concern, especially if you have a history of poor dental hygiene. 
7) Osteoporosis. Diabetes may lead to lower than normal bone mineral density, 
increasing your risk of osteoporosis. 
8) Pregnancy complications. High blood sugar levels can be dangerous for both 
the mother and the baby. The risk of miscarriage, stillbirth and birth defects 
are increased when diabetes isn't well controlled. For the mother, diabetes 
increases the risk of diabetic ketoacidosis, diabetic eye problems (retinopathy), 
pregnancy-induced high blood pressure and preeclampsia. 
9) Hearing problems. Hearing impairments occur more often in people with 
diabetes. 
TREATMENT FOR TYPE 1 DIABETES  
 Exercising regularly and maintaining a healthy weight 
 Eating healthy foods 
 Monitoring blood sugar 
 Taking insulin 
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The goal is to keep the blood sugar level as close to normal as possible to delay or 
prevent complications. Although there are exceptions, generally, the goal is to keep 
your daytime blood sugar levels before meals between 80 and 120 mg/dL (4.4 to 6.7 
mol/L) and your bedtime numbers between 100 and 140 mg/dL (5.6 to 7.8 mol/L). 
INSULIN 
Insulin is a peptide hormone, produced by the beta cells of pancreas and is central to 
regulate the blood glucose level in the body. Like most of the other hormones, insulin 
is a protein comprising of 2 polypeptide chains A (with 21 amino acid residues and B 
(with 30 amino acid residues) [Fig. 2]. Chains A and B are linked by disulphide 
bridges. In addition A-chain contains an intra-chain disulphide bridge linking residue 
6 and 11. The structure of insulin is shown in the fi gure 1 below. C-chain, which 
connect A and B chains is liberated along with insulin after breakdown of proinsulin. 
Insulin monomers aggregate to form dimers and hexamers
5
 .Zn hexamer is composed 
of three insulin dimmers associated in threefold symmetrical pattern.Patient with type 
1 diabetic insulin cannot be secreted in their body (pancreas). So it (insulin) must be 
injected externally. 
Figure 2 Structure Of Insulin
6 
 
 
 
CELLULAR ACTIONS OF INSULIN 
7 
Key insulin target tissues for regulation of glucose homeostasis are liver, muscle, and 
fat, but insulin also exerts potent regulatory effects on other cell types. Insulin 
stimulates intracellular use and storage of glucose, amino acids, and fatty acids and 
inhibits catabolic processes such as the breakdown of glycogen, fat, and protein. It 
does this by  
stimulating the transport of substrates and ions into cells, promoting the translocation  
of proteins between cellular compartments, activating and inactivating specific 
enzymes,  
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and changing the amounts of proteins by altering the rates of transcription and mRNA 
translation. 
Figiure  3:Action of insulin
8 
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Table: 1 classification of insulin preparation
9-12 
 
 
 
 
 
 
 
Type of Insulin Brand Name Generic Name Onset Peak Duration 
Rapid-acting NovoLog Insulin aspart 15 minutes 30 to 90 minutes 3 to 5 hours 
Apidra Insulin glulisine 15 minutes 30 to 90 minutes 3 to 5 hours 
Humalog Insulin lispro 15 minutes 30 to 90 minutes 3 to 5 hours 
Short-acting Humulin R Regular (R) 30 to 60 minutes 2 to 4 hours 5 to 8 hours 
Novolin R 
Intermediate-acting Humulin N NPH (N) 1 to 3 hours 8 hours 12 to 16 hours 
Novolin N 
Long-acting Levemir Insulin detemir 1 hour Peakless 20 to 26 hours 
Lantus Insulin glargine 
Pre-mixed NPH 
(intermediate-acting) 
and regular (short-
acting) 
Humulin 70/30 
 Novolin 70/30 
70% NPH and 30% regular 30 to 60 minutes Varies 10 to 16 hours 
Humulin 50/50 50% NPH and 50% regular 30 to 60 minutes Varies 10 to 16 hours 
Pre-mixed insulin 
lispro protamine 
suspension 
(intermediate-acting) 
and insulin lispro 
(rapid-acting  
Humalog Mix 75/25 75% insulin lispro 
protamine and 25% insulin 
lispro 
10 to 15 minutes Varies 10 to 16 hours 
Humalog Mix 50/50 50% insulin lispro 
protamine and 50% insulin 
lispro 
10 to 15 minutes Varies 10 to 16 hours 
Pre-mixed insulin 
aspart protamine 
suspension 
(intermediate-acting) 
and insulin aspart 
(rapid-acting) 
NovoLog Mix 70/30 70% insulin aspart 
protamine 
and 30% insulin aspart 
5 to 15 minutes Varies 10 to 16 hours 
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Each insulin has on own 
 Onset 
 Peak 
 Duration time. 
 Onset is how soon the insulin starts a lower the blood glucose  
 The peak is the time the insulin is working the hardest to lowering the blood 
glucose level. 
 Duration is the time at how long the insulin lasts the length to  keeps lowering 
the blood sugar 
The chart shows the different insulin has different onset, duration and peak. 
2. TYPE 2 DIABETES
13 
  Type 2 diabetes, once known as adult-onset or noninsulin-dependent 
diabetes, is a chronic condition that affects the way your body metabolizes sugar 
(glucose), your body's main source of fuel. 
  With type 2 diabetes, your body either resists the effects of insulin — a 
hormone that regulates the movement of sugar into your cells — or doesn't produce 
enough insulin to maintain a normal glucose level. Untreated, type 2 diabetes can be 
life-threatening. 
  It is the result of failure to produce sufficient insulin and insulin 
resistance. Elevated blood glucose levels are managed with reduced food intake, 
increased physical activity, and eventually oral medications or insulin 
SYMPTOMS OF TYPE 2 DIABETES 
Type 2 diabetes symptoms may develop slowly 
1) Increased thirst and frequent urination 
2) Increased hunger.  
3) Weight loss.  
4)  Fatigue 
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5) Blurred vision.  
6) Slow-healing sores or frequent infections.   
CAUSES TYPE 2 DIABETES 
1) Weight. Being overweight is a primary risk factor for type 2 diabetes. The 
more fatty tissue you have, the more resistant your cells become to insulin. 
2) Fat distribution. If your body stores fat primarily in your abdomen, your 
risk of type 2 diabetes is greater than if your body stores fat elsewhere, such 
as your hips and thighs. 
3) Inactivity. The less active you are, the greater your risk of type 2 diabetes. 
Physical activity helps you control your weight, uses up glucose as energy 
and makes your cells more sensitive to insulin. 
4) Family history. The risk of type 2 diabetes increases if your parent or 
sibling has type 2 diabetes. 
5) Race. Although it's unclear why, people of certain races — including 
blacks, Hispanics, American Indians and Asian-Americans — are more 
likely to develop type 2 diabetes than whites are. 
6) Age. The risk of type 2 diabetes increases as you get older, especially after 
age 45. That's probably because people tend to exercise less, lose muscle 
mass and gain weight as they age. But type 2 diabetes is also increasing 
dramatically among children, adolescents and younger adults. 
7) Prediabetes. Prediabetes is a condition in which your blood sugar level is 
higher than normal, but not high enough to be classified as diabetes. Left 
untreated, prediabetes often progresses to type 2 diabetes. 
COMPLAINTS TYPE 2 DIABETES 
1) Heart and blood vessel disease. Diabetes dramatically increases the risk of 
various cardiovascular problems, including coronary artery disease with 
chest pain (angina), heart attack, stroke, narrowing of arteries 
(atherosclerosis) and high blood pressure. The risk of stroke is two to four 
times higher for people with diabetes, and the death rate from heart disease 
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is two to four times higher for people with diabetes than for people without 
the disease, according to the American Heart Association. 
2) Alzheimer's disease. Type 2 diabetes may increase the risk of Alzheimer's 
disease and vascular dementia. The poorer your blood sugar control, the 
greater the risk appears to be. So what connects the two conditions? One 
theory is that cardiovascular problems caused by diabetes could contribute 
to dementia by blocking blood flow to the brain or causing strokes. Other 
possibilities are that too much insulin in the blood leads to brain-damaging 
inflammation, or lack of insulin in the brain deprives brain cells of glucose. 
3) Nerve damage (neuropathy). Excess sugar can injure the walls of the tiny 
blood vessels (capillaries) that nourish your nerves, especially in the legs. 
This can cause tingling, numbness, burning or pain that usually begins at 
the tips of the toes or fingers and gradually spreads upward. Poorly 
controlled blood sugar can eventually cause you to lose all sense of feeling 
in the affected limbs.  
4) Kidney damage (nephropathy). The kidneys contain millions of tiny 
blood vessel clusters that filter waste from your blood. Diabetes can 
damage this delicate filtering system. Severe damage can lead to kidney 
failure or irreversible end-stage kidney disease, requiring dialysis or a 
kidney transplant. 
5) Foot damage. Nerve damage in the feet or poor blood flow to the feet 
increases the risk of various foot complications. Left untreated, cuts and 
blisters can become serious infections. Severe damage might require toe, 
foot or even leg amputation. 
6) Skin and mouth conditions. Diabetes may leave you more susceptible to 
skin problems, including bacterial and fungal infections. Gum infections 
also may be a concern, especially if you have a history of poor dental 
hygiene. 
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TREATMENT TYPE 2 DIABETES
14-16 
 Diabetes mellitus type 2 is a chronic, progressive disease that has nl 
established cure, but does have well- established which can delay and sometimes 
which can delay and sometimes avoid most of the formerly inevitable of the 
condition. 
 They are two main goals of treatment. 
 Reduction of morality and concomitant morbidity (from 
assorted diabetic complication 
 Preservation of quality of life. 
Oral hypoglycemic drugs are used to maintain the blood glucose level  for some 
patient I have to take both oral drug and with insulin. 
 
ORAL HYPOGLYCEMIC DRUGS. 
a. Sulphonyl ureas – 
1. First generation 
i. Tolbutamide 
ii. Chlorpropamide 
2. Second generation  
i. Glibenglamide  
ii. Glipizide 
iii. Gliclazide and Glimiperide 
b. Biguanides 
1. Metformin 
c. Meglitinides 
a. Repaglinide 
b. Nateglinide 
d. Thiazolidine diones –  
a. Rosiglitazone 
b. Pioglitazone 
e. Alpha glucosidase inhibitors  
Acarbose, Miglitol 
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Mechanism of action. 
 Sulfonylurea’s bind to (KATP) channel on the cell membrane of pancreatic this 
inhibits a tonic, hyperpolarizing efflux of potassium, thus causing the electric 
potential over the membrane to become more positive. This opens voltage-
gated channels. The rises in intracellular calcium leads to increased fusion 
of granulate with the cell membrane, and therefore increased secretion of (pro) 
insulin. 
Figure  4: mechanism of action suphonylurea’s17 
 
 
Tolbutamide 
 Tolbutamide is a first generation This drug may be used in the management 
of if diet alone is not effective. Tolbutamide stimulates the secretion of by the. Since 
the pancreas must synthesize insulin in order for this drug to work, it is not effective 
in the management of. It is not routinely used due to a higher incidence of adverse 
effects compared to newer second generation sulfonylurea’s, such as it generally has a 
short duration of action due to its rapid metabolism, and is therefore safe for use in 
elderly diabetics. 
Glimiperide. 
 The primary mechanism of action of glimepiride in lowering blood glucose 
appears to be dependent on stimulating the release of insulin from functioning 
pancreatic beta cells. In addition, extrapancreatic effects may also play a role in the 
activity of sulfonylureas such as glimepiride. This is supported by both preclinical and 
clinical studies demonstrating that glimepiride administration can lead to increased 
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sensitivity of peripheral tissues to insulin. These findings are consistent with the 
results of a long-term, randomized, and placebo-controlled trial in which glimiperide 
therapy improved postprandial insulin/C-peptide responses and overall glycemic 
control without producing clinically meaningful increases in fasting insulin/C-peptide 
levels. However, as with other sulfonylureas, the mechanism by which glimepiride 
lowers blood glucose during long-term administration has not been clearly 
established. 
Glibenglamide. 
The drug works by binding to and activating the regulatory subunit of the  (KATP). 
This inhibition causes cell membrane opening. This results in an increase in 
intracellular in the and subsequent stimulation insulin release. 
After a cerebral ischemic insult is broken and glibenclamide can reach the central 
nervous system. Glibenclamide has been shown to bind more efficiently to the 
ischemic hemisphere. Moreover, under ischemic conditions SUR1, the regulatory 
subunit of the KATP- and the NCCa-ATP-channels, is expressed in neurons, atrocities, 
oligodendrocytes, endothelial cells and by reactive microglia. 
Gliclazide 
 Gliclazide selectively binds to sulfonylurea receptors on the surface of the 
pancreatic beta-cells. It was shown to provide cardiovascular protection as it does not 
bind to sulfonylurea receptors (n the heart This binding effectively closes the K+ ion 
channels. This decreases the efflux of potassium from the cell which leads to the 
depolarization of the cell. This causes voltage dependent Ca++ ion channels to open 
increasing the Ca++ influx. The calcium can then bind to and activate calmodulin 
which in turn leads to exocytose of insulin vesicles leading to insulin release 
Metformin 
 Metformin activates AMP activated protein kinase (AMPK) a liver enzyme 
that play an important role in signaling whole body energy balance and the glucose 
and fats activation of AMPK  is required for Metformin inhibitory effects on the 
production of liver glucose. 
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Figure 5: Mechanism of action of Metformin
18 
 
 
Repaglinide.  
 Repaglinide acts by stimulating release of insulin from the cells of the islets of 
pancreas inhibiting ATP-sensitive K+ channels, thereby activating the Ca++ channels 
with increase in intracellular calcium to release insulin. However, repaglinide acts on 
a different binding site than the sulphonylureas. Repaglinide is not effective in the 
absence of functioning beta-cells. Repaglinide increases the amount of insulin 
released in a natural and physiological pulsatile pattern the activity of repaglinide is 
dose-dependent. Mean insulin levels begin to rise approximately 1.5 hours after the 
pre-prandial dose of repaglinide and declines towards baseline levels between meal-
time the rapid onset of action and the short duration of hypoglycemic effect of 
repaglinide makes this agent suitable for pre-prandial administration. The main 
advantage of pre-prandial administration is that patients can miss or postpone a meal 
(and the corresponding repaglinide dose) without increasing the risk of hypoglycemia 
or compromising glycaemic control. 
Pioglitazone. 
 Pioglitazone is an oral drug that reduces the amount of glucose (sugar) in the blood. 
It is in a class of anti-diabetic drugs called thiazolidinediones that are used in the 
treatment .The other member in this class is . (Another member of this class, 
troglitazone or Rezulin, was removed from the market because of .) Patients with type 
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2 diabetes cannot make enough insulin, and the cells of their body respond less to the 
insulin that is produced. Since insulin is the hormone that stimulates cells to remove 
glucose from the blood, the reduced amount of insulin and its reduced effect cause 
cells to take up less glucose from the blood and the level of glucose in the blood to 
rise. Pioglitazone often is referred to as an "insulin sensitizer" because it attaches to 
the insulin receptors on cells throughout the body and causes the cells to become more 
sensitive (more responsive) to insulin. As a result, more glucose is removed from the 
blood, and the level of glucose in the blood falls. At least some insulin must be 
produced by the pancreas in order for pioglitazone to work. Pioglitazone also lowers 
the level of glucose in the blood by reducing the production and secretion of glucose 
into the blood by the liver. In addition, pioglitazone may alter the blood 
concentrations of lipids (fats) in the blood. Specifically, it decreases  and increases the 
"good" (HDL)  
Acarbose. 
 Acarbose inhibits enzymes, specifically, enzymes in the brush border of the 
small intestines and pancreatic alpha-amylase hydrolyzes complex starches to in the 
lumen of the small intestine, whereas the membrane-bound intestinal alpha-
glucosidase in the small intestine. Inhibition of these enzyme systems reduces the rate 
of digestion of complex carbohydrates. Less glucose is absorbed because the 
carbohydrates are not broken down into glucose molecule.  
 
III) GESTATIONAL DIABETES 
This type affects females during pregnancy. Some women have very high 
levels of glucose in their blood, and their bodies are unable to produce enough insulin 
to transport all of the glucose into their cells, resulting in progressively rising levels of 
glucose. Diagnosis of gestational diabetes is made during pregnancy. 
 
The majority of gestational diabetes patients can control their diabetes with exercise 
and diet. Between 10% to 20% of them will need to take some kind of blood-glucose-
controlling medications. Undiagnosed or uncontrolled gestational diabetes can raise 
the risk of complications during childbirth. The baby may be bigger than he/she 
should be. 
COMPLICATIONS GESTATIONAL DIABETES 
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i. Increased risk of prenatal mortality and morbidity. 
ii. Obesity or impaired glucose intolerance in the offspring 
accompanied by macrosomia 
iii. Neural tube defects 
iv. Prematurity syndromes 
CAUSES GESTATIONAL DIABETES. 
  Age > 30 years, obesity (BMI > 27.3 kg/m2), family history of diabetes, 
glycosuria, previous macrosomia, previous congenital malformation, previous 
stillbirth, past history of Gestational diabetes mellitus. 
 
TESTES FOR DIABETIC 
 Glycated hemoglobin (HbA1C) test. This blood test indicates your average 
blood. The term HbA1c refers to Glycated hemoglobin. It develops when 
hemoglobin a protein within red blood cells that carrier’s oxygen throughout 
the body. Joins in the blood becomes ―Glycated‖ by measuring Glycated 
hemoglobin (HbA1c), clinicians are able to get an overall picture of what is 
the average blood sugar level have been over a period of week or month 
 .Random blood sugar test. A blood sample will be taken at a random time. 
Blood sugar values are expressed in milligrams per deciliter (mg/dL) or mill 
moles per liter (mmol/L). Regardless of when you last ate, a random blood 
sugar level of 200 mg/dL (11.1 mmol/L) or higher suggests diabetes, 
especially when coupled with any of the signs and symptoms of diabetes, such 
as frequent urination and extreme thirst. 
 Fasting blood sugar test. A blood sample will be taken after an overnight 
fast. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is normal. 
A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is 
considered prediabetes. If it's 126 mg/dL (7 mmol/L) or higher on two 
separate tests, you have diabetes. 
DIABETIC INDUCED BY STREPTOZOTOCIN.
19 
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 Streptozotocin is a toxic glucose analogue that preferentially accumulates in 
pancreatic beta cells via the GLUT2 glucose transporter. Especially the Streptozotocin 
inhibits insulin secretion and causes a state of insulin dependent diabetes mellitus. 
Both effects can be attributed to its specific chemical properties, namely its alkylating 
potency as with  Streptozotocin its beta cell specificity is mainly the result of 
selective cellular uptake and accumulation. 
Beta cells selectivity of  Streptozotocin 
20
  
  Streptozotocin   is a nitrosourea analogue in which the N methyl N 
nitrosourea (MNU) moiety is linked to the carbon 2 of a hexose. The action of 
Streptozotocin and chemically related alkylating compounds requires their uptake into 
the cells. Nitrosourea are usually lipophilic and tissue uptake to a plasma membrane 
in rapid; hour as a result of the hexose substitution,  Streptozotocin is less lipophilic. 
Streptozotocin is selectively accumulated in pancreatic β cells via the low- affinity 
GLUT2 glucose transporter in the plasma membrane. Thus, insulin-producing cells 
they do not express this glucose transporter are resistant to Streptozotocin. This 
observation also explains the greater toxicity of Streptozotocin compared with N- 
methyl-N-nitrosourea in cells that express GLUT2, even though both substances 
alkylating DNA to a similar extent. The importance of the GLUT2 glucose transporter 
in this process is also shown by the observation that Streptozotocin damages other 
organs expressing this transporter, particularly kidney and liver. 
β cells toxicity 
 It is generally assumed that the toxicity of Streptozotocin is dependent up on the 
DNA alkylating activity of this methylnitrosourea moiety especially at the 6 position 
of guanine. The transfer of the methyl group Streptozotocin DNA molecules causes 
damage, which along a define chain of events, results in the fragmentation of the 
DNA. Protein glycosylation may be an additional damaging factor. In the attempt to 
repair DNA polymerase is over stimulated. This diminishes cellar NAD+ and 
subsequently ATP Ultimately responsible for beta cell death, but it is likely that 
protein methylation contributed to the functional defects of the beta cells after 
exposure to Streptozotocin 
Inhibition of insulin secretion by Streptozotocin 
 The effects of Streptozotocin on glucose and insulin homeostasis reflect the toxin 
induced abnormalities in beta cell function. Initially biosynthesis, glucose induced 
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insulin secretion and glucose metabolism is all affected. On the other hand 
Streptozotocin has no immediate direct inhibitory effect upon glucose transport or 
upon glucose stage of transport or upon glucose phosphorylation by glucokinase. 
However at later stages of functional beta cells impairment deficiencies in teams of 
gene expression and protein production lead to the deterioration of both glucose 
transport and metabolism  
 Even before the negative effect of mitochondrial DNA and protein alkylation 
and glycosylation become evident Streptozotocin induced depletion of NAD may 
result in the inhibition of insulin biosynthesis and secretion later inhibition of glucose 
induced and amino acid induced insulin secretion as a result of mitochondrial genome 
become apparent. This impairment is more marked for nutrient that for non nutrient 
insulin secretion. This interpretation has been confirmed through studies which have 
shown that pre treatment of isolated pancreatic islet with polymerase inhibitor 
nicotinamide prevents early inhibition of beta cells function beta cell function during 
first day after Streptozotocin exposure while long term inhibition of insulin secretion 
6 days after Streptozotocin exposure 
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MECHANISM OF ACTION OF STREPTOZOTOCIN. 
 
STZ 
 
Enter beta cells 
 
Via glucose transporter 
 
Alkylation of DNA 
 
Activity of poly ADP ribosylation 
 
Depletion of NAD and ATP 
 
Enhance ATP dephosphorylation 
 
Super oxide radicals 
 
Hydrogen peroxide free radical 
 
Hydroxyl radicals 
 
Liberate toxic amount of NO  
 
DNA damage  
 
Hyperglycemia and hypoinsulinemia 
 
 
Antidiabetic Activity And Toxicity Studies Of Ethanolic Extract Of Polialthia Longifolia 
Roots 
 
RVS College of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 21 
 
HERBAL MEDICINE TODAY 
 In recent years, there has been renewed interest in the treatment against 
different diseases using herbal drugs as they are generally non-toxic and World 
Health Organization has also recommended the evaluation of the effectiveness 
of plants in condition where we lack safe modern drugs. Plant derivatives 
with hypoglycemic properties have been used in folk medicine and traditional 
healing systems around the world from very ancient time. Despite the 
introduction of hypoglycemic agents from natural and synthetic sources, 
diabetes and its secondary complications continue to be a major medical 
problem to people
21 
.Medicinal plants used to treat hypoglycemic and 
hyperglycemic conditions are of considerable interest to ethno 
botanical community as they are recognized to contain valuable medicinal 
properties in different parts of the plant. There are a large number of plants and 
natural biomolecules that have been discussed in literature for their antidiabetic 
effects. For example, plants have been used since ancient times to prevent 
conditions associated with diabetes 
22
. There is a growing interest in herbal 
remedies, because of their effectiveness, minimal side effects in clinical 
experience, and relatively low cost. Herbal drugs or their extracts are 
prescribed widely; even their biologically active compounds are unknown
23
 .In 
many developing countries, traditional medicine, in particular the herbal 
medicine, is sometimes the only affordable source of healthcare
24
 Even the 
WHO (World Health Organization) approves the use of plant drugs for 
different diseases, including diabetes mellitus
25
 This mini review aims to 
discuss some key aspects related to the potential use of plants and natural 
biomolecules for the prophylaxis and treatment of type 2 diabetes as well as 
the potential mechanisms of action. 
In traditional medicine diabetes mellitus is treated with diet, physical exercise 
and medicinal plants, even though, more than 1200 plants are used around the 
world in the control of diabetes mellitus and approximately 30% of the 
traditionally used ant diabetic plants were pharmacologically and chemically 
investigated. On the other hand, potential hypoglycemic agents have also been 
detected for more than 100 plants used in ant diabetic therapy. Traditional 
treatments may provide the valuable clues for the development of new oral 
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hypoglycemic agents and simple dietary adjuncts. More than 100 medicinal 
plants are mentioned in the Indian system of medicines including folk 
medicines for the management of diabetes, which are effective either 
separately or in combinations 
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2.LITERATURE REVIEW 
 
 
Kashalkar Rhreeajas V et al
26
 was carried out the preliminary studies of 
P.longifolia seeds to investigate its potentialities. The preliminary phytochemical 
evaluation of various extracts indicated that the seeds are rich source of alkaloids, 
tannins, phenols, flavonoids and carbohydrates. Loss on drying and moisture content 
experiments was carried out to know the presence of volatile organic matters. 
 
 Raja Sidambaram R et al
27
 was evaluated the antioxidant activity of seed 
extracts of Polyalthia longifolia. Petroleum ether, chloroform, methanol and 
aqueous extracts of seeds of P.longifolia were prepared and evaluated by 
preliminary phytochemical screening followed by antioxidant activity using 
DPPH and FRAP assays. The phytochemical analysis showed the major active 
compound present in all the four extracts as terpenoids. Among the various 
extracts methanol and petroleum ether extracts showed good antioxidant 
activity and aqueous extract showed very low activity in both the antioxidant 
assays. The study confirmed the antioxidant activity of different seed extracts of 
P.longifolia and can be used for further drug formulation studies. 
 
 S Kaviya et al28 was synthesized the Synthesis of silver nanoparticles 
(AgNPs) using Polyalthia longifolia leaf extract. The reaction is carried out at two 
different concentrations (10−3M and 10−4 M) of silver nitrate, and the effect of 
temperature on the synthesis of AgNPs is investigated by stirring at room temperature 
(25◦C) and at 60◦C. The UV-visible spectra of NPs showed a blue shift with 
increasing temperature at both concentrations. FT-IR analysis shows that the 
biomoites played an important role in the reduction of Ag+ ions and the growth of 
AgNPs. TEM results were utilized for the determination of the size and morphology 
of nanoparticles. The synthesized silver nanoparticles are found to be highly toxic 
against Gram-positive bacteria than Gram-negative bacteria.   
 
 Prashith Kekuda T.R et al
29
 determining antimicrobial activity of leaf and 
pericarp (ripe and unripe) extracts of Polyalthia longifolia . Antibacterial activity 
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of leaf and pericarp extracts was determined against Staphylococcus aureus, 
Salmonella typhi and Klebsiella pneumoniae by Agar well diffusion assay. 
Antifungal activityof leaf and pericarp extracts was tested against Sclerotium 
rolfsii by Poisoned food technique. The extracts were effective against S. aureus 
to higher extent when compared to Gram negative bacteria. The extracts caused 
marked inhibition of mycelial growth of S. rolfsii. Unripe pericarp extract 
exhibited marked inhibition of bacteria and fungus when compared to other 
extracts. Preliminary phytochemical analysis of extracts revealed the presence of 
flavonoids, tannins, steroids and glycosides in leaf and pericarp extracts. The 
observed inhibitory potential could be ascribed to the presence of secondary 
metabolites in the extracts.  
 Jayaraman Rajangam et al
30
 was hepatoprotective and antioxidant potential 
of methanolic extract of Polyalthiya longifolia fruits (MEPL) by in-vitro and in-vivo 
methods.In the invitro study, Freshly isolated rat primary hepatocytes and HepG2 
cells were exposed with CCl4 along with/without various concentrations of 
MEPL(125,250,500 μg/kg) and the effects were studied.In the in-vivo studies, CCl4 
intoxication method was used and aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), total bilirubin and total proteins 
were estimated and supported with histopathological studies.MEPL (125,250,500 
μg/kg) treated animals increased the percentage of viability in both primary 
hepatocytes (p<0.001) and in HepG2 cells (p<0.01) where as in the invivo 
studies,MEPL produced significant hepatoprotective effect by decreasing the elevated 
serum enzymes, bilirubin, LPO and significantly increased the levels of glutathione 
(GSH), catalase (CAT) and super oxide dismutase (SOD) .Moreover, in-vitro 
antioxidant studies revealed that 
MEPL scavenged free radicals and maximum percentage of inhibition was 62% at 
800μg/mL. 
 
 Aparna Lakshmi et al
31
 was evaluated by estimating the blood glucose level, 
total protein, total cholesterol, creatinine and blood urea and nitrogen in alloxan 
induced diabetic rats. The wound healing activity property was studied by excision 
and incision methods.There is a significant decrease in the blood glucose levels from 
1 week to 3 week in n-hexane extract, ethyl acetate and methanolic extract treated 
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groups when compared to the diabetic control group. The n-hexane extract treated 
group has shown significant increase in the total cholesterol, creatinine and urea 
levels when compared to the other treated groups and is almost similar to the standard 
group. In contrast the methanolic extract has brought has brought the total protein 
level to the normal in diabetic induced rats.  In conclusion the present study indicated 
a significant antidiabetic effect of the methanolic extract of Polyalthia longifolia and 
supports its traditional usage in the control of diabetes. It was found to have strong 
wound healing property. Further studies are required for the detailed studies in 
isolation of the compounds and pharmacological investigations of the bark 
constituents, which possess its own traditional claim. 
Yang Chang Wu et al
32
 isolated Three new clerodane diterpenes, (4→2)-
abeo-cleroda-2,13E-dien-2,14- dioic acid (1), (4→2)-abeo-2,13-diformyl-cleroda-
2,13E dien-14-oic acid (2), and 16(R&S)- methoxycleroda-4(18),13-dien-15,16-
olide (3), were isolated from the unripe fruit of Polyalthia longifolia var. pendula 
(Annonaceae) together with five known compounds (4-8). The structures of all 
isolates were determined by spectroscopic analysis. The anti-inflammatory activity 
of the isolates was evaluated by testing their inhibitory effect on NO production in 
LPS-stimulated RAW 264.7 macrophages. Among the isolated compounds, 16-
hydroxycleroda-3,13-dien-15,16-olide (6) and 16-oxocleroda-3,13- dien-15-oic 
acid (7) showed promising NO inhibitory activity at 10 μg/mL, with 81.1% and 
86.3%, inhibition, respectively.  
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3. PLANT PROFILE 
 
…..Polyalthia longifolia33 …. 
TAXONOMICAL CLASSIFICATION 
34   
  
Table: 2 – Taxonomical classification of Polyalthia longifolia 
Kingdom  Plantae  
Division Magnoliophyta 
Class Magnoliopsida 
Subclass    Asteridae 
Order Magnoliales; 
Family  Annonaceae 
Genus Polyalthia; 
Species longifolia 
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Table: 3 – Vernacular names of Polyalthia longifolia 35 
 
 
 
 
Distribution and habitat
36
: 
 
 Polyalthia longifolia cv. pendula (Annonaceae) is native to the drier regions 
of India and is locally known as ―Ashoka‖ and is commonly cultivated in India, 
Pakistan, and Sri Lanka 
Description:  
The plant grows throughout the tropical and subtropical parts of India up to an 
altitude of 1500 m. A tall, evergreen, handsome, pyramid-like, columnar, tree: main 
stem straight, undivided, growing up to 12 m or more. Branches slender, short, about 
1-2 m long, glabrous, and pendulous. Leaves alternate, exstipulate, distichous, mildly 
aromatic, 7.5-23 by 1.5-3.8 cm, shining, glabrous, narrowly lanceolate, tapering to a 
fine acuminate apex, margin markedly undulate, pinnately veined, leathery or 
subcoriaceous, shortly petiolate; petiole about 6 mm long. Flowers arise from 
branches below the leaves, nonfragrant, 2.5-3.5 cm across, yellowish to green, in 
fascicles or shortly pendunculate umbels; petals 6, 2 seriate, flat, from a broad base, 
lanceolate, long accumulate, spreading; and sepals 3, broad, short, triangular, the tips 
reflexed. Stamens many, cuneate; connective truncately dilated beyond the cells. 
Ovaries indefinite; ovules 1-2; style oblong. Ripe fruits ovoid, 1.8-2 cm long, 
numerous, stalked, glabrous, 1 seeded; stalk 1.3 cm long, short, glabrous. Seeds 
smooth, shining. Flowering and fruiting: February-  
 
CHEMICAL CONSITUVENTS 
 P. longifolia mainly contains diterpenoids,[27] alkaloids, tannins, and 
mucilage. The chief components of the plant are O-methylbulbocapnine-N-oxide (1), 
English Ashoka, 
Hindi Deodari 
Tamil Asogu 
Bengali Debdaru 
Malayalam Aranamaram 
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polyfothine (2), N-methylnandigerine-N-oxide (3), oliveroline-N-oxide (4), 
pendulamine A (5), N-pendulamine B (6), 8-oxopolyalthiane (7), 16-oxo-5 (10), 13-
halimadien-15-oic acid (8), 16-Oxo-3, 13-clerodadien-15-oic acid (9), 16-
hydroxycleroda-3, 13-dien-16, 15-olide 
 
Uses
36
:  
Almost all parts of the plant are used in the Indian traditional system of 
medicine for the treatment of various ailments in human beings. In Ayurveda, 
particularly, the bark of P. longifolia has significant medicinal properties. 
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4. AIM AND OBJECTIVE 
It is divided into following phase-  
PHASE   I : Taxonomical studies. 
 Collection of plants. 
 Authentication of plants. 
 Powdered the root materialls 
 PHASE II :Pharmacognostical studies. 
 Successively solvent Extraction. 
 Alcohol (ethanol). 
 Preliminary Phytochemistry screenings. 
 Alkaloids 
 Saponins. 
 Tannins 
 Amino acid 
 Flavonoids 
 Terpenoids 
 Protein 
 Steroids 
 
PHASE III :Pharmacological studies. 
 Acute toxicity studies (as per OECD guidelines) 
 Induction of diabetic animal 
 Induces diabetic in rats by STZ 
 Measuring the body weight 
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 Measuring the water intake 
 Measuring the food intake 
 Determination of lipids 
o Triglyceride 
o Total cholesterol 
o HDL 
o VLDL 
PHASE IV : Result and Documentation. 
   Evolution of statistical significance result by computer aided 
program and systemic documentation. Values were presented as mean SEM Data 
were analyzed using of variance (ANOVA) and group means were compared with 
Turkey’s post hoc Multiple Comparison Test using SPSS software version 17. P<0.05 
is considered as significant.  
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PLAN OF WORK 
 Literature review 
 
Selection of plant 
 
Collection of plant  
 
Authentication of plant 
 
Powdered the leafs 
 
Extraction of powered plant leafs 
 
 
Phytochemical Screening       Pharmacological Screening 
 
 Alkaloids      Acute toxicity studies 
 Saponins      Diabetic induced by STZ 
 Tannins      Measuring serum glucose 
 Flavonoids       Measuring  body 
weight 
 Terpeniods      Determination of lipid  
 Proteins etc., 
   
Result and discussion 
 
Conclusion 
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5. MATERIALS AND METHOD 
 
Chemicals : 
 Streptozotocin. 
 Glibenclamide 
 Petroleum ether 
 Ethanol 
 Benzene 
 Chloroform 
 Studies were carried out in albino rats. 
 
TAXONOMICAL STUDIES. 
1) Collection of plants. 
  P. Longifolia was produced from the Botany Central council for 
Research in Ayurvedia and Siddha Govt of India. 
  The freshly collected sample were thoroughly cleaned and soaked in 
fresh water repeatedly to separate mud particles sticking on to plant constituents. The 
plants constituents collected were cut into small bits of about 2-3 in size. After the 
leafs of the plants are powdered with a mechanical grinder. This powder was 
subjected to various studies for which the materials and methods which is presented 
below. 
 2) Authentication of plant. 
   The dried whole plant powder of P. Longifolia Roots was 
supplied and authenticated by Chelladurai.v research officer Botany Central council 
for Research in Ayurvedia and Siddha Govt of India. 
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PHARMACOGNOSTICAL STUDIES. 
Extraction procedure. 
Figure 7: Assembly extraction Apparatus 
 
 
 
Equal amount of the weighed powder were mixed and placed in the Soxhlet 
apparatus by using ethanol. From the 500gm of crude powder was extracted with 2.5 
liter of ethanol  (60 – 80) by continuous hot percolation using Soxhlet apparatus. This 
can be continued up to 24 hours.. After the extraction process filtered and the Soxhlet 
is removed the obtained residue is stored in the dissector.  
 
PHYTO CHEMICAL SCREENING
37-39
 
The plant may be containing the following compound such as carbohydrate, 
protein, and lipids. That is utilized as food by man. It also contains the compound 
like. Tannins, glycosides, alkaloids. Volatiles oils. The compound that is responsible 
for lots of medicinal properties 
  
TEST FOR CARBOHYDRATES  
 Molish test 
   The sample powdered was added with 1 ml of alpha naptool solution 
along with conc Sulphuric acid solution in the test tube reddish colour was 
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produced at the junction between 2 liquid this is shows the presence of 
carbohydrate. 
 Fehling test. 
  To the sample powder was added with both Fehling A and Fehling B 
solution and placed in the water bath for a sufficient time. This shows the 
brick red colour. It shows the presence of carbohydrate. 
 Benedicts test. 
  To the sample powder add 8 drops of benedicts reagents and voil the 
sample vigorously for 5 min it shows the red ppt. this shows the presents of 
carbohydrate. 
TEST FOR ALKALOIDS 
 To the small of stored powder (sample) was taken and add few drops of 
hydrochloric acid and filtered. 
   The filtered was tested with various alkaloid agents., 
 Mayer’s reagents: 
  To a small of above filter add small quantity of Mayer’s reagent to 
form cream precipitate. This shows the presence of alkaloids. 
 Dragendorffs reagents 
  From the above filter add small amount of Dragendorffs reagents it 
forms a orange brown precipitate. This shows the presents of alkaloids. 
TEST FOR FLAVONOIDS 
  To the filter of the plant extract add 5 ml of dilute ammonia solution 
and followed by the addition of concentrated sulphuric acid. It forms a yellow 
colour. It shows extract indicated the presence of flavonoids. 
TEST FOR STEROIDS. 
 Salkowaski test 
  Few amount of plant extract was mixed with chloroform and the same 
volume of sulphuric acid is added on it. Cherry red colour was obtain in the 
chloroform layer. This shows the sample contain steroids. 
Libbbermann burchatd test: 
  The extract is dissolved in 2 ml of chloroform 10 drops of acetic acid 
and conc. Sulphuric acid were added. Now the solution becomes reddish 
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colour then it turns to bluish green colour. This shows the plant extraction 
indicates the presents of steroids. 
TEST FOR TANNINS. 
 From few amount of plant extract is treated with vanillin hydrochloric acid 
reagent. It forms, pink or red colour due to the formation of phloroglucinol, it 
indicate the presence of tannins. 
TEST FOR PROTEIN. 
 Mellon’s reagents. 
  Mellon’s reagents (mercuric nitrate in nitric acid containing a trace of 
nitrous acid) usually yields a white precipitate on addition to a protein solution 
which turns red on heating.  
 Ninhydrin Test. 
   From the sample solution add 2 drops a freshly prepared 0.2% 
ninhydrine reagent was added to the extract and heating. Development of blue 
colour may indicate the presence of peptide, amino acid (PROTEIN). 
TEST FOR GLYCOSIDES: 
 Keller- killani test. 
  From the small quantity of small powder acetic acid was dissolved and 
adds few drops of ferric chloride and transferred to the surface of conc 
Sulphuric acid. At the junction, reddish brown colour was formed, which 
gradually becomes blue indicates the presents of cardiac glycosides. 
TEST FOR SAPONINS. 
 Foam test: 
  1 ml of extract solution is diluted separately with distilled water to 20 
ml and shaken in a graduated cylinder for 15 minutes. A 1 cm layer of foam 
indicates the presence of Saponins. 
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PHARMACOLOGICAL STUDIES. 
TOXICITY STUDY
40
. 
ACUTE TOXICITY STUDY 
Experimental Protocol 
Guideline                        : OECD-423 
CPCSEA Ref. No           : IAE1012/c/06/CPCSEA     
Test                                  : Limit test 
Species                             : Rattus norvegicus 
Strain                                : Albino Wistar rats 
Number of animals           : 10 animals (5 for each kashayams) 
Sex                                    : Female 
Initial dose                         : 5mg/kg     
Route of administration     : Oral  
Duration                             : 3 hr close observation, followed by 14 days observation 
Others                                 : Body weight, mortality status 
Parameters                          : CNS, ANS and behavioral changes 
Blood collection                  : Not needed       
Sacrifice                               : On day 14 after oral administration 
 
Table 4- EXPERIMENTAL DESIGN 
 
GROUP DOSE (mg/kg) 
Group 1 5 
Group 2 50 
Group 3 300 
Group 4 2000 
   
 
STUDY DESIGN 
Selection of Test animal 
 Female adult Wistar rats of 8-12 weeks are selected. Nulliparous and non-
pregnant animals were obtained from the centralized animal house of RVS College of 
Antidiabetic Activity And Toxicity Studies Of Ethanolic Extract Of Polialthia Longifolia 
Roots 
 
RVS College of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 37 
 
Pharmaceutical sciences, Sulur and they are acclimatized for holding 1 week prior to 
dosing. 
Housing and feeding conditions 
Temperature - As per OECD GUIDELINE-420 the temperature of animal house is 
maintained at 22
0
C±3
0
C. 
Humidity - The relative humidity of animal room maintained at 50-60% preferably 
not exceeds 70% (OECD guidelines-420, 2001). Otherwise there may be chances of 
developing lesions such as ring tail and food consumption may be increased. 
Light – The sequence of light used is 12 hrs light and 12 hrs dark. 
Caging – Polypropylene cages with solid bottom and walls. The lids are made up of 
stainless steel grill which is capable to hold both feed and water.  
Feeding condition and feed – Sterile laboratory feed (ad libitum) and water daily. 
The feed used is brown coloured chow diet. 
Drug administration  
 Animals are fasted prior to dosing (food but not water should be withheld for 
overnight).After that animals are weighed and the test substance administered. The 
healthy rats has been taken and divided into 4 different groups. Then the petroleum 
ether extract was dissolved in 0.6% if sodium carboxyl methyl cellulose on equal. The 
test substance is administered in a single dose by oral gavages, using a curved and ball 
tipped stainless steel feeding needle. 
Clinical observation 
All animals were monitored continuously with special attention for 4 hrs after dosing 
for signs of toxicity. Additional observations are also done for the next 14 days for 
any other behavioral or clinical signs of toxicity. Weight changes are calculated. At 
the end of the test animals are weighed and then humanely killed andLD50 values are 
established. 
SUB ACUTE TOXICITY STUDY 
Experimental Protocol 
Guideline                         : OECD-407 
CPCSEA Ref. No            : 1012/c/06/CPCSEA     
Species                              : Rattus norvegicus 
Strain                                 : Albino Wistar rats 
Number of animals            : 10 for each groups 
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Sex                                     : Male/Female 
Route of administration      : Oral  
Duration                              : 28 days 
No. of blood collection          : 2 
Duration of blood collection : 0
th 
day, 28
th 
day 
Blood collection route            : Retro orbital 
Sacrifice                                  : After 28 days of oral administration 
Body weight recording           : weekly intervals 
 
Table 05-EXPERIMENTAL DESIGN FOR SUBACUTE TOXICITY STUDIES 
 
Groups Dose No. of 
animals 
Group 1 Control 10(5M+5F) 
Group 2 Low dose 10(5M+ 5F) 
Group 3 Medium dose 10(5M+ 5F) 
Group 4 High dose 10(5M+ 5F) 
 
STUDY DESIGN 
Selection of Animals 
Male and Female rats were selected and are acclimatized for 5 days prior to 
the start of study. The females are nulliparous and non-pregnant. At the 
commencement of study the weight variation of animals used minimal and not exceed 
± 20 % of the mean weight of each sex. Repeated dose oral study was conducted as a 
preliminary to a long term study preferably animals from the same strain and source 
were used in both studies. 
Housing and feeding conditions 
The temperature in the experimental animal room was maintained at 22
0
C 
(±3
0
C). The relative humidity was 50-60% (not exceed 70%) and the lighting 
sequence was 12 hrs light and 12 hrs dark. For feeding, conventional laboratory diet 
was used with an unlimited supply of drinking water. Animals were housed in small 
groups of same sex (NMT 5 animals in each cage) 
Preparation of animals 
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Healthy young adult animals were randomly assigned to control and treatment 
groups. Cages were arranged in such a way that possible effects due to cage 
placement were minimized. The animals were identified uniquely and kept in their 
cages for five days prior to the start of the study to allow for acclimatization to the 
laboratory conditions. 
 
Table 6-Dose of drug for Sub acute Toxicity Studies 
 
Group Treatment 
I Control 
II Therapeutic dose 
III Medium dose 
IV High dose 
 
Dose administration 
The leaf extracts were administered by oral gavages. Ten animals (5 males and 
5 females) were used at each dose level for each extracts. Three test groups and a 
control group were used for both extracts and the highest dose level was chosen with 
the aim of inducing toxic effects but not death or severe suffering. Thereafter a 
descending sequence of dose levels selected with a view to demonstrating dosage 
related response and non-observed-adverse effects at the lowest dose level (NOAEL). 
The animals were dosed with test substance daily 7 days each week for a period of 28 
days.  
FUNCTIONAL OBSERVATIONAL BATTERY (FOB) OBSERVATIONAL 
PROCEDURES                  
Home-cage observation 
The animals were observed closely from outside the cages without agitating 
them; body position, respiration, clonic involuntary movement, tonic involuntary 
movement, vocalizations and palpebral closures were noted
41
.  
Hand-held observations 
The reactions of the animals were observed when they were removed from 
their cages and held. Reactivity, palpebral closure, lacrimation, salivation and pilo 
erection were noted. Detail any finding related to dirtiness of hair cast, bite marks, 
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missing nails, gauntness (stomach could be touched, median vertebrae protrude) or 
death (findings)
 42
.  
Open field activity 
Each animal was gently placed in the centre of a field and made the following 
10 observations for 3 minutes 
43
 
a) Rearings  
b) clonic involuntary movement  
c) Tonic involuntary movement  
d) Gait d) Movements  
e) Arousal f) Stereotype 
 g) Abnormal behavior  
h) Defecations  
i) Urinations.  
Stimulus response 
Approach response; touch response, eyelid reflex, pinna reflex, sound 
response, tail pinch response, tail flick latency, pupillary reflex, righting reflex 
observations were carried out: 
Eyelid reflex assessment 
       The animal’s eyelid was touched with a dull object (cotton buds) and blinking 
response was noted.  
Pinna reflex assessment 
         This is to assess the sensor motor activity of the animals. The fine object 
(cotton) was slightly touched inside the ear of the animals. The time duration taken 
for the response was noted.  
Sound response assessment 
         In order to assess the sensor motor activity of the animals, the fingers snapped 
above and behind the animals head. The time duration taken for the flinch and flicks 
were scored.  
Pupillary response assessment 
            The pen light was shined in the eyes of the animals. The response to 
contraction was scored.  
Response to visual stimuli 
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             The blunt object was approached the animals head and held the object 1 to 2 
inch from the animal’s head for few seconds. The time duration taken for approaching 
the object was recorded. 
Tail flick latency assessment 
        This method was used to assess the sensor motor status of the animals
40
 
Response to painful stimuli was measured by the tail flick method using 
anlgesiometer. In this the animals were exposed to noxious stimulus like radiant heat 
and tail flick latencies (the time required for the flicking of tail i.e. the reaction time 
and a mean of two pre drug recordings were taken as basal value(0minute). A cut off 
time of 10 seconds was maintained in order to prevent tissue injury (based on the 
reaction time that generally varied between 3-4 seconds). 
Tail pinch response 
          This was used to assess the sensor motor activity of the animals and the 
response to painful stimuli was measured in this method. The animal’s tails were 
lightly pinched approximately 2 inch from the tip with the help of forceps. Recordings 
were noted.  
 
NERVOUS AND MUSCLE MEASUREMENTS 
Motor coordination assessment 
           For the evaluation of coordination and balance, the rotarod test was carried out. 
The apparatus consists of a horizontal metal rod positioned 25cm above a switch 
floor. The rod was divided in to four parts by plastic plates so that four rats could be 
tested at a time. Rats were positioned on the rod rotating at a constant speed of 20 rpm 
and the time the rat could stay on the rod without falling was recorded
44
.  
Locomotor activity assessment 
           Locomotor activity is determined by using actophotometer and this is to assess 
the neuromuscular status of the animals. The animals were placed on the digital 
actophotometer. The locomotion of the animals was recorded.  
Righting reflex assessment 
            This is also used to assess the neuromuscular status of the animals. In this the 
animals are placed on their back. The ability to regain a position on all four legs was 
recorded.  
Landing foot splay assessment 
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This method was used to assess the neuromuscular status of the animals. The 
animals were grasped by the scruff of the neck and base of the tail. The paws were 
marked with ink and held above the bottom at a height of 1 ft. The animals were 
released and the distance between the heels was measured. The foot play distance was 
measured.  
Body weight 
The body weights were recorded at the study Day 0, weekly during the study 
and at scheduled necropsy. 
 
Feed and water consumption 
 Food consumption was assessed on a daily basis by weighing the feeders and 
expressed as grams per rat per day. Water consumption was measured. 
Hematology and biochemistry 
A complete battery of haematological, clinical chemistry, and urinalysis 
measurements were taken at baseline and during the final week of the study on the 
animals per sex from each dose group.  The selected animals were placed in metabolic 
cages, during which time urine was collected for urine analysis. Blood was also 
collected from the animals for fasting glucose analysis. 
Haematological parameters evaluated included haemoglobin, packed cell 
volume (PCV); erythrocyte count, leukocyte count (total and differential), Mean 
corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean 
corpuscular haemoglobin concentration (MCHC) were calculated and reported. 
Clinical chemistry parameters evaluated on separated serum samples included 
alkaline phosphates (ALP), SGOT, SGPT,  Albumin, Protein, glucose, urea, 
creatinine,  serum TSH level. 
All surviving test and control animals were sacrificed at study termination by 
cervical dislocation under anaesthesia and subjected to a complete necropsy. The 
organs were harvested and weighed and relative organ weights (g/kg body weight) 
were calculated using terminal body weights. 
Gross pathology 
All animals in the study were subjected to a full, detailed gross necropsy 
which includes careful examination of the external surface of the body, all orifices, 
and the cranial, thoracic and abdominal cavities and their contents. The liver, kidneys, 
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adrenals, testes, epididymis, prostate with seminal vesicle with coagulating glands as 
a whole, thymus, spleen, brain and heart of all animals (apart from those found 
moribund and/or intercurrently killed)  trimmed of any adherent tissue, as appropriate, 
and their wet weight taken.  
The following tissues were preserved in the most appropriate fixation medium 
for both the type of tissue and the intended subsequent histopathological examination: 
all gross lesions, brain, liver, kidneys, adrenals, spleen, heart, thymus, trachea and 
lungs (preserved by inflation with fixative and then immersion), epididymis, prostate 
+ seminal vesicle, lymph and peripheral nerve.  
Statistical methods 
Body weight data were analyzed using a one-way analysis of variance 
followed by Dennett’s multiple comparison tests P<0.05 was considered to be 
statistically significant. One-way analysis of variance (ANOVA) was used in 
analyzing body weight change, organ weight, and food and water consumption. 
PHARMACOLOGICAL SCREENING 
Male Swiss albino rats weighing 150-200g were used for the present work. 
The animals used for the experiment were maintained under standard laboratory 
conditions in an animal house of RVS College of Pharmaceutical sciences approved 
by the committee for the purpose of control and supervision on experiments on 
animals (Ref.No: IAE1012/C/06/CPCSEA) under 12 h dark/light cycle and controlled 
temperature 24±2
0
C. They had free access to food and water ad libitum. The animals 
were acclimatized to the laboratory for a period of 7 days, before the commencement 
of experiment.  
Oral glucose tolerance test
44,45 
The ability of an individual rat to handle a standard oral glucose load was 
evaluated by assessing the blood plasma for glucose level. Study on Oral Glucose 
Tolerance Test (OGTT) initially, hypoglycemic activity of herbal formulation was 
carried out in overnight fasted normal rats, which were equally divided into four 
groups of six rats each. Normal control group received only vehicle (1 ml of water) 
and test group received the formulation in three different dose level ie low, 
therapeutic and high dose respectively.  Following 30 min post extract administration 
all the animals were fed with glucose (2 g/kg). Blood samples were collected from tail 
vein prior to dosing and then at 30, 60, 90 and 120 min after glucose administration. 
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The fasting blood glucose level was analyzed using glucose-oxidase-peroxide reactive 
strips (Accu-chek, Roche Diabnostics, GmbH, Germany). 
   ANTIDIABETIC ACTIVITY 
INDUCTION OF DIABETICS
46-48 
  Six adult albino rats weighting 250-300 grams (75-90 days old) were 
used for inducing diabetes. The animals were injected by Streptozotocin at the dose of 
55 mg/kg of the body weight intravenously. Streptozotocin induces diabetes within 3 
days by destroying the beta cells. Diabetic animals and non-diabetic control group 
were kept in metabolic cages individually and separately and under feeding and 
metabolism control. Glucose in the blood of diabetic rats exceeded that of the non-
diabetic control ones. Food consumption was measured in terms of (gr.), water 
consumption was measured in terms of (ml) and urine volume was measured in terms 
of (ml) on a daily basis while every 2-4 weeks in 80 days the levels of C-peptide, 
insulin and glucose in blood serum were also measured, so that chemical diabetes was 
verified in rats injected with Streptozotocin  
ASSESSMENT OF DIABETIC. 
 Diabetic was conformed after 48 hr of streptozotocin injection, the blood 
samples were collected through retro orbital puncture and plasma glucose level were 
estimated by enzymatic GOD POD diagnostic kit method. The rat having fasting 
plasma glucose levels more than 250 mg/dL were selected and used for this study. 
 
EVALUATION OF EXTRACT ON STREPTOZOTOCIN INDUCED DIABETIC 
RATS. 
 The albino rats on either sex have been selected for the experimental study. The 
weight of the should be around 170-240 gm. The animals are divided into six groups. 
Each group has 6 animals. 
   Group 1was kept as normal (normal rat) received only distilled 
water; group 2 was kept as negative control, Streptozotocin induced and received 
only water. Group 3 was treated with glibenclamide (10mg/kg) Group 4, 5 and 6 is 
diabetic induced rat and treated with 100mg/kg,200mg/kg and 400mg/kg b.w of 
ethanol extract of Polialthia longifolia.(EPLR)    
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Table 7 - Evaluation Of Extract On Streptozotocin Induced Diabetic Rats 
 
S no Groups Treatment 
1 Group I Normal control 
2 Group II Diabetic control 
3 Group III Diabetic + glibenclamide(5 mg/kg) 
4 Group IV Diabetic + Extract  Lower dose 
5 Group V Diabetic + Extract  Middle Dose 
6 Group VI Diabetic + Extract  Higher Dose 
 
 
  EPLR was administered for 21 days at a three different dose levels 100, 200 
and 400mg/kg. Dried extract made in aqueous and given orally. The blood was 
collected by sinus orbital under the light diethyl ether anesthesia. The blood was 
centrifuged at 3000 rpm for 10 minutes. Body weight glucose was analyzed every 
week and lipid and lipoprotein profile from serum (TC, TG, HDL, LDL, VLDL.) 
were analyzed after 28 days. 
 
OBSERVATION  
  Serum glucose level estimation (initial and final) 
  Body weight of the albino rats (initial and final) 
ESTIMATION OF LIPIDS. 
TOTAL CHOLESTEROL
49 
The cholesterol in serum was estimated by using ecoline diagnostic kit. 
Cholesterol and its ester were released from lipoprotein by detergents cholesterol 
estrates hydrolyses the ester the sub subsequent enzymatic oxidation by cholesterol 
oxidize, Hydrogen peroxidase was formed. This was converted into colored 
quininemine in a reaction with 4- aminopyantipyrine and phenol catalyses by 
peroxidase the observance of the sample and of the standard was measured against the 
reagent blank value at 546nm. Cholesterol level in serum was expressed as mg/dL. 
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TRIGLYCERIDES. 
 The triglyceride level was estimated by using Ecoline diagnostic kit. 
Triglyceride        Lipase   Glycerol + Fatty acid 
Triglyceride  GK   Glycerol + Fatty acid 
Glycerol 3 phosphate + O2  GPO    Dihydroxy acetone phosphate+  
                  
H2O2 
2H2O2 + Aminoantipyrine + 4 chlorophenol    POD        Chinonimine +  
          
 4H2O 
 The absorbance of the sample and of the standard was measured against 
reagent blank value at 546nm. Triglyceride level in serum was expressed as 
mg/dL. 
HDL CHOLESTEROL 
  The cholesterol was separated from the serum after precipitation of 
LDL cholesterol by phosphotungstic acid precipitating reagent. The 
supernatant. After centrifugation was estimated using Ecoline diagnostic kit. 
The absorbance of sample and of the standard was measures against the 
reagent blank value at 546 nm. HDL cholesterol level in serum was expressed 
as mg/dL. 
LDL CHOLESTEROL. 
 The LDL Cholesterol is calculating by following formula 
LDL Cholesterol = Total cholesterol – [HDL cholesterol – Triglyceride / 5]. 
 LDL cholesterol level in the plasma is calculated and expressed in the unit of 
mg/dL. 
VLDL CHOLESTEROL. 
  The VLDL Cholesterol is calculating by following formula 
VLDL Cholesterol = Total cholesterol – HDL cholesterol – Triglyceride-LDL. 
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6. RESULTS 
Table 8 - Soxhlet Extraction Of Polialathia Longifolia Roots 
 
Plant Part used 
Method of 
Extraction 
Solvents 
Weight of 
Powder 
taken 
(A) 
Wight of 
product 
(B) 
Percentage 
Yield 
( W/V) 
 
Polialthi
a 
longifoli
a 
 
ROOT 
 
Continuous Hot 
percolation by 
Soxhlet apparatus 
 
Ethanol  
(60-80°C) 
50 2.88 5.96 
 
A = Weight of powder plant material  
B = Weight of extract  
Percentage yield = (B/A) X 100 
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Preliminary phyto chemical screening. 
  EEPLR extracts was subjected various chemical tested as per the standard 
methods for the identification of the various constituents. The result if this phyto 
chemical analysis is listed below. 
Table-9 Qualitative phyto chemical screening of EPLR 
Plant constituent 
Ethanolic 
Extract 
Steroids - 
Carbohydrate + 
Flavonoids + 
Proteins and amino acids - 
Glycosides - 
Alkaloids - 
Saponins + 
Volatile oil + 
Tannins - 
      ―+‖ Presence,  ―-‖ Absence. 
 
TOXICITY STUDIES 
ACUTE TOXICITY STUDIES 
Acute toxicity studies on the albino rats show no morality at a dose of 
2000mg/kg, during a time period of 14 days. During the study, no noticeable were 
seen in the rats. This help to predict that it does not contain any type of toxicity and it 
is full safe. So 200 mg/kg b.w (1/10
th
 and 500mg/kg b.w (1/4
th
) and 1000mg/kg (1/2
th
 
) were selected of that dose for the further study. 
 
Antidiabetic Activity And Toxicity Studies Of Ethanolic Extract Of Polialthia Longifolia 
Roots 
 
RVS College of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 49 
 
SUBACUTE TOXICITY STUDIES 
Functional observations are necessary to test the neurotoxic effects in the 
assessment of the toxic effects of ICFE. The functional observational battery is a non-
invasive procedure designed to detect gross functional deficits in animals resulting 
from exposure to chemicals and to better quantify neurotoxic effects detected in other 
studies. This battery of test is not intended to provide a detailed evaluation of 
neurotoxicity. It is designed to be used in conjunction with neuropathologic 
evaluation and/or general toxicity testing. Additional functional is necessary to assess 
completely the neurotoxic potential of drug. 
Table 10- Effect of  EPLR on Stimulus Response 
Parameters Observations 
Approach response 
Slowly approaches, sniffs 
and pulls back/normal 
Touch response Slowly retreats/normal 
 
Eyelid response 
 
Blinks/normal 
 
Pinna reflex 
Auricle twitches/normal 
 
Sound response 
Mild reaction, hears 
sound/normal 
 
Tail flick response 
 
Flicks the tail or normal 
 
Pupillary reflex 
 
Contracts 
 
Righting reflex 
 
Lands on four limbs/normal 
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Table-11: Effect of EPLR on Autonomic Observations 
S L 
N O 
 
Parameters 
 
Observations 
1 Reactivity Easy/normal 
2 Handling 
Did not resist, very easy 
to handle 
3 Palpebral closure Normal (eyes are open) 
4 Lacrimation No lacrimation 
5 Salivation No salivation 
6 Piloerection None/normal 
7 Hair coat Normal 
8 Bite marks None 
9 Nail status Normal 
10 Rearing activity Normal 
11 Clonic involuntary movement None 
12 Tonic involuntary movement None 
13 Gait Normal 
14 Movements Normal 
15 Arousal 
Normal (keeps guard up 
and engages in 
exploratory activity) 
16 
Stereotype behaviour (preening, squeaking, shaking 
head and other repetitive behavior 
None 
17 
Abnormal behaviour (squirming, running backwards, 
labored movements, squealing) 
 
None 
 
 
 
 
 
 
 
Antidiabetic Activity And Toxicity Studies Of Ethanolic Extract Of Polialthia Longifolia 
Roots 
 
RVS College of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 51 
 
Table 12- Effect of EPLR on Nervous and Muscle Measurements 
 
Parameters Observations 
Abdominal tone Normal (proper hardness) 
Limb tone Normal 
Motor coordination No abnormal changes 
Landing foot splay 
No significant difference 
between control 
 
Table 13 Effect of EPLR on Motor Coordination Assessment 
Group Control Low dose Medium dose High dose 
 
Male 
 
10.21±0.66 
 
12.58±0.93 
 
11.65±0.84 
 
12.03±0.82 
 
Female 
 
10.8±0.52 
 
12.3±0.98 
 
11.74±0.78 
 
10.78±0.65 
Values are expressed as mean±SEM (N=5) and not significant statistically. 
 
Figure 8: Effect of EPLLR on Motor coordination Assessment 
    
 
 
 
 
Antidiabetic Activity And Toxicity Studies Of Ethanolic Extract Of Polialthia Longifolia 
Roots 
 
RVS College of Pharmaceutical Sciences, Dept. of Pharmacology, Sulur, Coimbatore Page 52 
 
Table 14- Effect of EPLR on Locomotors Activity Assessment 
 
Group Control Lower dose Middle Dose Higher Dose 
Male 141.3±2.02 145.4±4.15 141.±2.77 138.2±3.16 
Female 153.6±2.65 122.2±3.10
* 
126.6±3.37 124.2±2.58 
              
   Values expressed as Mean±SEM, number of animals in each group=6; * P <0.05 
Figure 9: Effect of EPLR on locomotors activity 
  
 
Table 15-Effect EPLR on Righting reflex Assessment 
  
Group Control Lower Dose Middle Dose Higher Dose 
Male 1.39±0.28 1.48±0.44 1.38.±0.432 1.44±0.248 
Female 1.68±0.44 1.53±0.26
 
1.34±0.25 1.42±0.25 
  Values are expressed as Mean±SEM;  
Number of animals in each group=5, not significant statistically. 
Figure 10: Effect of EPLR on righting reflex  
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Table 16- Effect of EPLR on Tail Flick Latency 
Group Control Lower Dose Middle Dose Higher Dose 
Male 0.93±0.30 1.04±0.27 1.06±0.41 1.03±0.21 
Female 0.92±0.03 1.08±0.22 1.09±0.26 1.01±0.23 
 
Value are expressed as Mean ± SEM 
Number of animals in each group=5, not significant statistically 
 
Figure 11: Effect of EPLR on Tail Flick Latency 
 
 
Table 17- Effect of EPLR on Pinna Reflex Assessment 
Group Control Lower Dose Middle Dose Higher Dose 
Male 2.10±0.20 2.08±0.37 2.06±0.41 2.10±0.32 
Female 2.03±0.03 2.00±0.22 2.04±0.47 2.05±0.43 
 
Values are expressed as Mean±SEM. 
 Number of animals in each group=5; Values- NS 
Figure 12: Effect of EPLR on pinna reflex assessment 
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Table 18 - Effect of EPLR on Sound Response Assessment 
 
Group Control Lower Dose Middle Dose Higher dose 
Male 0.7±0.10 0.7±0.17 0.6±0.31 0.7±0.23 
Female 0.6±0.06 0.5±0.20 0.6±0.45 0.6±0.42 
 
Values are expressed as Mean±SEM.  
Number of animals in each group=5; Values- NS 
 
Figure 13: Effect on EPLR on Sound Response Assessment 
 
Table 19-Response To EPLR On Visual Stimuli 
Group Control Lower dose Middle dose Higher Dose 
Male 1.8±0.20 1.7±0.18 1.6±0.32 1.7±0.23 
Female 1.6±0.42 1.5±0.24 1.6±0.47 1.7±0.32 
 
Values are expressed as Mean±SEM;  
Number of animals in each group=5; Values-NS 
Figure 14: Effect on EPLR on visual stimuli 
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Table 20- Effect of EPLR on Percentage Change In Body Weight 
 
Sex 
 
Dose 
Days % change 
in body 
wt 
 
0 
 
7 
 
14 
 
21 
 
28 
M
a
le
 
 
Control 
 
129.4±3.2
6 
 
139.8±2.3
7 
 
148.2±2.33 
 
158.8±1.85 
 
169.8±3.15 
 
31.22±0.9 
 
Lower 
Dose 
 
137.2±2.8
2 
 
144.4±1.6
9 
 
154.6±1.63 
 
164.±2.07 
 
173.8±2.70 
 
26.6±2.4 
 
Middle 
dose 
 
131.2±2.3
5 
 
135.4±4.3
1 
 
139.09±0.8
9 
 
145.5.±1.51 
 
146.8±1.59 
 
0.4±2.5 
 
Higher 
Dose 
 
135.4±4.0 
 
133.±2.55 
 
138.8±2.53 
 
143.4.±2.42 
 
148.1±1.70 
 
15.3±1.4 
F
em
a
le
 
 
Control 
 
123.9±3.2
0 
 
130±3.92 
 
139.4±3.76 
 
150±5.15 
 
160.2±4.32 
 
29.6±3.81 
 
Lower 
Dose 
 
125.2±2.9
2 
 
129±2.43 
 
127.1±4.2 
 
134.1±4.16 
 
140.8±3.26 
 
15.06±3.2 
 
Middle 
dose 
 
122.4±2.2
7 
 
133±2.40 
                            
132.8±2.06 
 
138.2±2.18 
 
142.2±1.24 
 
20.2±1.3 
  
Higher 
Dose 
 
123.2±2.6
5 
 
125.6±2.1
8 
 
128.8±1.28 
 
134.6±1.20 
 
141.6±1.99 
 
18.4±4.2 
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Figure 15: effect of EPLR on body weight 
 
 
Table 21 –Effect of EPLR on Relative Organ Weight  
 
Sex Group Brain Heart Liver Kidney 
M
al
e 
Control 1.35±0.12 5.18±.12 5.63±3.4 5.73±.43 
Low dose 1.37±.13 5.20±1.3 5.731.2±1.22 5.82±.26 
Medium dose 1.34±1.5 5.25±1.3 5.80±3.2 5.90±3.5 
High dose 1.40±2.3 5.28±2.3 5.85±1.2 5.99±4.2 
F
em
al
e 
Control 1.50±1.56 5.82±.34 5.83±.45 6.12±1.3 
Low dose 1.45±2.34 5.94±1.76 5.92±2.43 6.23±.23 
Medium dose 1.40±3.53 6.15±.54 6.12±.4 5.98±2.7 
High dose 1.42±1.43 6.27±.32 5.85±6.3 6.09±6.4 
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Figure 16: Effect of EPLR on organ weights 
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Table 22-Effect of EPLR on serum biochemical parameter 
Sex Group Days 
Hb 
g/dl 
RBC 
×10
6
mm
3 
WBC 
( ×10
3 
Mm
3
) 
Differential WBC count 
N 
% 
L 
% 
E 
% 
M 
% 
B 
% 
M
a
le
 
 
Control 
0 7.8±2.34 2.67±0.67 7.07±0.31 32.56±7.89 65.8±7.15 0.93±1.3 0 0 
28 7.9±1.00 2.72±0.32 6.87±.62 32.66±7.09 65.66±7.63 0.67±0.58 0 0 
Lower Dose 
0 7.8±2.3 2.56±0.65 7.1±.88 29.93±4.54 67.8±7.23 1.20±1.48 0 0 
28 7.7±2.02 2.42±0.60 7.3±.63 30.33±4.50 68.66±3.51 1.21±1.00 0 0 
 
Middle Dose 
0 7.8±2.3 2.67±0.88 7.06±.31 29.01±12.54 71±2.72 0.67±2.88 0 0 
28 8.2±1.25 2.72±0.45 6.86±.62 28.33±10.5 72±10.00 0.67±0.58 0 0 
 
Higher dose 
0 7.6±2.54 2.64±0.76 7.2±.31 32.66±4.43 66.43±11 1.22±1.30 0 0 
28 7.7±0.57 2.59±0.15 7.4±.32 33.35±9.07 65.33±8.50 1.30±0.58 0 0 
F
em
a
le
 
 
Control 
0 7.9±2.34 2.67±0.67 6.50±2.2 32.56±7.89 64.8±7.15 0.92±1.3 1.4±0.64 0.4±0.78 
28 7.9±1.00 2.72±0.32 7.00±1.57 31.66±7.09 65.66±7.63 0.67±0.58 1.5±0.57 0.6±0.69 
 
Lower Dose 
0 7.7±2.3 2.56±0.65 5.9±2.2 30.93±4.54 66.8±7.23 1.33±1.48 1±1.4 0.4±0.54 
28 7.7±2.02 2.42±0.60 6.01±1.52 30.33±4.50 66.66±3.51 1.26±1.00        0 0.8±0.83 
Middle Dose 
0 7.8±2.3 2.67±0.88 7.084±2.99 29.01±12.54 72±2.72 0.68±2.88 1±1 0.5±0.8 
28 8.2±1.25 2.72±0.45 6.56±8.6 28.33±10.5 74±10.00 0.69±0.58 0.4±0.5 1.0±1.0 
 
Higher Dose 
0 7.6±2.54 2.64±0.76 6.65±1.38 33.66±4.43 67.43±11 1.20±1.30 0.9±0.83 0.2±0.44 
28 7.7±0.57 2.59±0.15 6.85±4.2 34.33±9.07 68.33±8.50 1.17±0.58 0 0.2±0.4 
 
Values are expressed as Mean ± SEM; not significant statistically. 
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Table 23-Effect of EPLR on serum biochemical parameter 
 
Sex Group Days 
Serum  
creatinine  
mg/dl 
Serum SGOT Serum SGPT 
M
A
L
E
 
Control 
O day   1.3 ±0.34 22.22±3.42 30.09±1.21 
28
th
 day   1.2 ±0.2 21.63±5.51 31.13±1.21 
Lower Dose 
O day   1.36 ±0.31 29.56±5.34 29.99±5.64 
28
th
 day   1.46 ±0.23 24.87±7.08 28.03±5.58 
Middle Dose 
O day   1.40 ± 0.42 34.67±9.89 37.98±9.61 
28
th
 day   1.83 ± 0.2  36.613±10.39 40.40±9.61 
Higher dose 
O day   1.32 ± 0.2  29.97±12.42 34.0±15.32 
28
th
 day   2.25±0.28 30.95±14.26 34.9±14.17 
F
E
M
A
L
E
 
Control 
O day   0.9 ±0.44     35.84±1.34 42.53±4.24 
28
th
 day   0.89 ±0.4     36.2±5.03 40.23±1.83 
Lower Dose 
O day   1.06 ±0.20     39.02±4.13 41.84±4.7 
28
th
 day   1.18 ±0.13     40..04±2.2 40.84±4.3 
Middle Dose 
O day   1.36 ± 0.42     40.05±6.4 46.34±5.56 
28
th
 day   1.76 ± 0.2     38.95±5.4 47.32±4.32 
Higher Dose 
O day   1.05 ± 0.21     36.02±2.1 39.35±3.3 
28
th
 day   2.07±0.28     39.04±4.22 40.43±5.23 
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HISTOPATHOLGICAL ASSESSMENT OF EPLR Extracts 
Figure 17 - T.S of rat liver showing normal cells in subacute toxicity study of EPLR                                      
 
  
Control Lower dose 
  
Medium dose Higher dose 
Microscopic appearance- 
   Section studies from the liver shows normal lobular architecture. 
Individual hepatocyte, central vein and sinusoids shows p- unremarkable. There is no 
evidence of inflammation and necrosis. 
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KIDNEY 
Figure 18 - T.S of rat kidney showing normal cells in Sub Acute Toxicity Studies of 
EPLR 
Microscopic appearance 
Section studies from the kidney show normal cortex and medulla. The glomeruli, 
interstitium and blood vessels are unremarkable. There is no evidence of inflammation 
and necrosis. 
  
Control Lower dose 
  
Medium dose Higher dose 
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HEART  
Figure 19 - T.S of rat heart showing normal cells in Sub Acute Toxicity Studies of 
EPLR 
Microscopic appearance- 
   Section studies from the heart shows normal myocardium with 
myocytes. There is no evidence of myocytic degeneration or edema. 
  
Control Lower dose 
  
Medium dose Higher dose 
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BRAIN 
Figure 20 - T.S of rat heart showing normal cells In Sub Acute Toxicity Studies Of 
EPLR 
 
 
Microscopic appearance- 
   Section studies from the brain shows normal cerebellum. Brain 
parenchyma, purkinjic cells and basal ganglion unremarkable. There is no evidence of 
inflammation and necrosis. 
 
  
Control Lower dose 
 
 
Medium dose                             Higher dose 
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ANTIDIABETIC ACTIVITY 
Oral glucose tolerance test 
In the OGTT the EPLR extracts at  a dose of 200mg/kg significantly reduced the 
blood glucose level at 30 minutes after glucose administration. Standard drug 
glibenclamide produced activity at all the time interval tested 
TABLE 24- ORAL GLUCOSE TOLERANCE TEST OF EPLR 
 
All value are expressed as mean ± SEM (n=6) 
Figure 21 - ORAL GLUCOSE TOLERANCE TEST OF EPLR  
 
Group 
Blood glucose levels (mg/dl) 
0 min 30 min 1st hour 2 nd hour 3rd hour 8th hour 
Control 
84.5 ± 
1.14 
121.4 ± 
1.52 
162.91 ± 
13.67 
139± 
2.074 
111.02 ± 
5.805 
93.4 ± 1.304 
Glibenglamide 
mg/kg 
87.5 ± 
10.164 
70.3 ± 
7.19 
84.0 ± 
10.271 
83.6 ± 
13.342 
81.2 ± 
7.791 
80.2 ± 7.328 
 EPLR 100mg/kg 84.3 110.8 143.12 130.12 128.12 125.22 
EPLR 200mg/kg 
85.6 ± 
5.263
*
 
83.6 ± 
6.894
*
 
83.6 ± 
1.924
*
 
90.2± 
2.408
*
 
80.4 ± 
1.517
*
 
84.4 ± 2.302
*
 
EPLR 400mg /kg 88.5±1.22 81.5±0.22 79.05±1.22 79.3±2.5 79.5±2.5 80.3±2.1 
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EFFECT OF EPLR ON SERUM GLUCOSE LEVEL 
 
Table 25- -Effect of EPLR on serum glucose level in normal control and STZ 
induced diabetic rats 
All values are expressed in MEAN ± SEM (n=6) 
Figure 22 : Effect of serum glucose level in normal control and STZ induced 
diabetic rat 
 
 
S.NO 
 
TREATMENT 
SERUM GLUCOSE LEVEL 
Initial 7
th
 day 14
th
 day 21
st
day 28
th
 day 
1. Normal control 90.97±1.47 94.97±1.47 104.3±4.1 102±2.13 89.52±2.16 
2 Diabetic control 104.22 259.3±3.51 303.2±5.5 375.1±1.3 405.3±1.26 
3. 
Diabetic + 
Standard 
104.12±1.2 267.8±3.15 150.1±1.4 140.2±0.5 129.5±1.0 
4. 
Diabetic+ Extract 
100mg/kg 
85.11±5.5 238.0±2.65 270.5±2.3 
299.88±1.
1 
325.2±2.46 
5. 
Diabetic+ Extract 
200mg/kg 
98.2±1.22 241.9±1.25 240.1±0.7 235.1±1.7 224.2±2.49 
6 
Diabetic+ Extract 
400mg/kg 
94.1±5.5 260.8  98.3±1.5 113±1.3 110±3.89 
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EFFECT OF EPLR ON BODY WEIGHT 
There was gradual increase in body weight in normal control while the diabetic 
control continues to lose the weight. However treated diabetic group gained 6.25%, 
8.24% as compared with the diabetic control and diabetic treated towards normal range. 
Extract changes in the body weight shows in the tables. 
 
Table 26 -Effect of EPLR on body weight in normal control and STZ induced 
diabetic rats. 
SL 
NO 
 
TREATMENT 
BODY WEIGHT 
Initial 7
th
 day 14
th
 day 21
st
day 28
th
 day 
1. Normal control 242.9±3.5 247.8±1.33 254.1±2.333 263.11±8.5 274±1.95 
2. Diabetic control 248.9±1.4 221.8±5.55 215.1±2.4 198.1±3.9 189±1.64 
3. 
Diabetic + 
Glibenclamide. 
243.5±1.5 230.2±4.88 245.1±2.3 260.1±1.34 275.8±1.6 
4. 
Diabetic+ Extract 
200 
243.2±2.5 228.1±4.6 245.1±3.4 260.5±6.7 282.8±2.7 
5. 
Diabetic+  Extract 
500 
250.5±3.2 240.1±1.22 260.11±3.8 280.1±2.3 303.2±2.8 
6. 
Diabetic + Extract 
1000 
241.6±3.8 230.1±4.8 245.9±2.78 254.1±3.44 260.1±1.4 
All value are expressed mean ±SEM (n=6) 
P<0.001, as compared to diabetic control  
P<0.001 as compared to Normal control. 
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Figure 23 : Effect on EPLR on Body weight 
 
 
Effect of EPLR on Serum lipids 
STZ diabetic rats group were found to have significantly increased VLDL, LDL, 
TG, TC level and markedly decreased HDL level as compared to normal control group. 
Treatment with EPLR extract 200mg/kg, 500 mg/kg and 1000mg/kg reduced 
significantly VLDL, LDL, TG, TC, levels and markedly increased HDL level as 
compared to diabetic control groups. Positive control was significantly preventing the 
increasing the serum TC, TG, LDL, VLDL and decreasing the HDL level as compared to 
diabetic group. Thus the extract treatment restored all these changes near to normal value. 
This change in serum is listed on the table. 
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Table 27--Effect Of EPLR On Serum Lipid And Lipoprotein Profile In 
Normal Control And STZ Induced Diabetic Rats 
 
All value are expressed as mean ±SEM (n=6) 
P<0.001, as compared to diabetic control 
P<0.001 as compared to Normal control. 
Table in parenthesis indicate % fall in body weight as compared to initial value. 
 
 
 
S.N
O 
 
Treatment 
TC(mg/
Dl) 
TG(mg/
Dl) 
HDL(m
g/Dl) 
LDL(mg/
Dl) 
VLDL 
(mg/Dl) 
 
1. 
 
Normal control 
 
87.16±4.5 
 
85.62±1.6 
 
42.5±1.32 
 
91.4±1.07 
 
46.5±1.32 
 
2. 
 
Diabetic control 
 
155.8±7.4 
 
189.86±4. 
 
20.3±1.42 
 
129±1.78 
 
53.3±2.18 
 
3. 
Diabetic + 
Glibenclamide 
(10mg/kg) 
92.3±2.35 101±2.90 45.4±1.48 102±2.56 33.2±1.65 
 
4 
 
Diabetic + extract 
(200mg/kg) 
 
135.3±3.9 
 
145.1±2.6 
 
47.3±2.1 
 
110.±2.62 
 
41.3±1.56 
 
5. 
Diabetic + extract 
(500mg) 
 
132±3.52 
 
112±3.01 
 
45.3±1.35 
 
102±2.12 
 
33.2±2.06 
 
6. 
Diabetic + extract 
(1000mg) 
 
89.3±1.03 
 
62.3±3.65 
 
3.82±1.37 
 
98.6±1.68 
 
26.71±2.1
8 
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Figure 24 : Effect of EPLR on Serum Lipid Level 
 
 
 
Values are expressed as mean ± SEM of 6 animals in each group
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7. DISCUSSION 
Phytochemical screening 
Qualitative Phytochemical screening and ethno botanical survey on the 
Polyaltehia longifolia root extracts the presented of certain phyto constitutions 
such alkaloids, tannins, carbohydrates, glycosides, terpenoids, high amount of 
volatile oils. The phytochemical constituents such as glycosides, tannins, 
triterpenoids, flavonoids, alkaloids may be linked to the anti diabetic activity. 
Acute toxicity studies 
To check the safety profile of the EPLR it was subjected to the acute 
toxicity study which conformed the absence of any toxicity or mortality at the 
higher dose of 2000mg/kg. Thus the EPLR can be classified as a safe drug 
category according to the Global harmonized Classification System quoted in the 
OECD guidelines 1996. 
 Based on the Toxicity studies 200mg/kg is used as a dose of extract and 
middle dose 500mg/kg(Dose×2.5) and higher dose as 1000mg/kg (Dose×5) used 
for sub-acute toxicity studies. 
Sub-acute toxicity studies 
 Sub-acute toxicity study was done and the results shows nontoxic nature 
of both the EPLR. Also, all the animals from control and all the treated groups up 
to dose 1000 mg/kg survived throughout the dosing period of 28 days. Animals 
from all the treated groups exhibited comparable body weight gain with that of 
controls throughout the dosing period.. No significant changes in the organ weight 
were observed. Furthermore no specific cell damage was noticed by the 
microscopic examination. The central and autonomic profiles were normal 
throughout the study and no specific alterations were noticed. 
The results of the effect of the extract on the body weight of the animals 
compared with vehicle are as shown in Table 24 and Fig. 17. There were no 
significant increases in the weight of animals treated with 200 mg ICFE. 
However, there were little amount of weight reduction body weight in middle 
dose and higher dose treated animals.  
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The results of the effect of EPLR on absolute organ weights of male and 
female rats are as shown in Table 21. Macroscopic examination did not show any 
changes in the colour of organs of the treated animals compared with vehicle. 
There were no significant changes in the relative weights of the liver, kidney and 
heart in both males and females. Treatment had no effect on spleen, stomach and 
testes of male rats.  
 
Hematological analysis and Biochemical analysis conducted at the end of 
the dosing period revealed no abnormalities attributable to the treatment. 
Effect of ICFE on blood sugar level  
Streptozotocin treatment will produce significant increase in serum 
glucose level with respective normal control group. The administration of ERLR 
100mg/kg, 200 mg/kg and 400mg/kg and glibenclamide 10 mg/kg significantly 
reversed the increase in serum glucose concentration in Streptozotocin induced 
rats. The extract changes in the serum glucose level are shown in the table. 
Diabetic mellitus (DM) is an endocrine disorder in which the glucose 
metabolism is impaired because of total loss of insulin after destruction of 
pancreatic beta cells or because of inadequate release of insulin from the 
pancreatic cells of beta cells. The fundamental mechanism underlying 
hyperglycemia involved over population and decreases utilization of glucose by 
the tissue. In the presence study was observed that whether the EPLR extract have 
the effect of lipid profile, anti-oxidant system or not and in addition to its 
antihyperglycaemic action of STZ induced diabetic in albino rats. 
 
Streptozotocin a beta cytotoxic induces diabetic in a wide variety of 
animal species including rats by selectively damaging the insulin secreting beta 
cells of pancreas i.p injection of STZ produces fragmentation of DNA of beta 
cells of pancreas which stimulates poly (ADP ribose and deflects NDA ultimately 
leading of destruction of beta cells and it is evidenced by clinical symptoms of 
hyperglycemia. 
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Dose dependent of the effect of the glibenclamide showed rapid 
normalization of blood glucose due to its insulin releasing effects. 
In our present study there was a significant weight gain EPLR treated the 
diabetic rats compared with the normal control rats and this observation shows 
anabolic effect of the EPLR on body weight on the diabetic rats. 
Hyperglycemia and insulin resistance both seem to have important in the 
pathogenesis of macro vascular complications. Diabetes mellitus causes a 
disturbance in the uptake of glucose as well as glucose metabolism. The 
hyperglycemia in the diabetes might inhibit tissue repair in the macro vascular 
beds. In the present study of EPLR treated group shows hypoglycemic activity 
and it confirms the presence of the anti- diabetic activity. Sulfonylurea such as 
glibenclamide is often used as a standard drug in the STZ induced diabetic to 
compare to the efficacy of antihyperglycaemic compound. In study there was a 
significant elevation in blood glucose level in the diabetic control group as 
compared with normal animal. The ICFE treated group exhibited significant 
reduction of fasting plasma glucose level as compared to the diabetic control 
group. Over production of glucose by means excessive hepatic glycogenolysis 
and gluconeogenesis is one of the fundamental basis of hyperglycemia in diabetes 
mellitus. 
The most common observed lipid abnormalities in diabetics are 
hypertriglyceridemia and hypercholesterolemia. A marked increase in total 
cholesterol and decrease in HDL cholesterol have been observed in diabetics 
control rats. Insulin deficiency results in failure to activate the lipoprotein lipase 
thereby causing hypertriglyceridemia. There was a significant control of the level 
of serum lipids in EPLR treated diabetic rats. In diabetes, LDL carries cholesterol 
to the peripheral tissue where it is deposited, where HDL transports cholesterol 
from peripheral tissue to the liver and this aids its excretion. Hence increase in 
LDL is atherogenic. In our present study, there was a significant decrease in 
triglyceride LDL and T.C levels, where as there was a significant increase in the 
HDL level. 
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Diabetes is a common chronic ailment for which the patient has to take 
insulin to maintain the blood sugar level. It is interesting to see how the EPLR 
tackles this problem. It corrects the function of pancreas, stimulating it to produce 
insulin in the natural way, which in turns way to maintain the blood sugar level. 
EPLR revitalizes and rejuvenates the organs, the dysfunction of which is causing 
the disease. This bring back normal functioning of the organs. It is also 
maintaining the healthy state body. Since no artificial chemical are involved, it 
doesn’t cause any side effects 
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8. SUMMARY AND CONCLUSION 
The presented study is an attempt to investigate the effect of petroleum 
ether extract of EPLR on Streptozotocin induced diabetic in albino rats. 
The Phytochemical study was screening showed the presence of tannins, 
carbohydrate, Flavonoids and reducing sugar which is responsible for the anti-
diabetic activity. 
  The animals were induced with STZ at a dose of 55mg/kg intraperatoneal 
and the diabetic animals were treated with EPLR (100, 500, 1000mg/kg) for 28 
days orally. The serum glucose, body weight lipid profile, liver glycogen were 
measured from the pancreas homogenate were measured which showed 
significant activity. 
The finding of the presence investigation suggests the EPLR has potential 
for its evaluation as protective agents against toxicity induced by Streptozotocin. 
Clinical assessments of EPLR determination of underlying mechanism of 
the protective effects in interesting topics requiring further study.  
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